Panvitan

Role

Indications

Reactions

Concomitant

Prophylaxis	24.9%
Pleural Mesothelioma Malignant	16.1%
Cancer Pain	9.6%
Hypertension	6.7%
Constipation	5.3%
Lung Adenocarcinoma Stage Iv	4.9%
Insomnia	4.1%
Non-small Cell Lung Cancer	3.5%
Pain	3.3%
Prophylaxis Of Nausea And Vomiting	3.1%
Lung Adenocarcinoma	2.8%
Lung Adenocarcinoma Recurrent	2.4%
Nausea	2.1%
Diabetes Mellitus	1.9%
Rash	1.8%
Lung Adenocarcinoma Metastatic	1.6%
Gastritis	1.5%
Neoplasm Malignant	1.5%
Product Used For Unknown Indication	1.4%
Cough	1.2%

White Blood Cell Count Decreased	26.6%
Renal Impairment	10.5%
Interstitial Lung Disease	8.2%
Vomiting	6.8%
Pyrexia	6.5%
Platelet Count Decreased	6.1%
Pneumonia	5.4%
Rash	3.7%
Lung Disorder	3.0%
Hepatic Function Abnormal	2.8%
Neutrophil Count Decreased	2.8%
Thrombocytopenia	2.8%
Hyperkalaemia	2.1%
Pleural Effusion	2.1%
Renal Failure Acute	2.1%
Rhabdomyolysis	1.9%
Syncope	1.9%
Disseminated Intravascular Coagulation	1.6%
Off Label Use	1.6%
Rash Pruritic	1.6%